Literature DB >> 7332856

Language dysfunction in schizophrenia.

R Faber, M B Reichstein.   

Abstract

Similarities between language disorders in aphasia and formal thought disorder in schizophrenia are explored in 24 schizophrenic, 5 manic and 5 depressed psychiatric in-patients, and 28 normal controls. Eight sub-tests from the Boston Diagnostic Aphasia Examination, a picture naming test and the Token test were administered. Schizophrenics with formal thought disorder showed significant abnormalities compared to all other groups, particularly on the Token Test and the repetition of phrases test. These deficits are suggestive of language comprehension and repetition dysfunctions in a substantial minority of rigorously defined schizophrenics.

Entities:  

Mesh:

Year:  1981        PMID: 7332856     DOI: 10.1192/bjp.139.6.519

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Neuropsychological dysfunctions among chronic schizophrenia patients, alcohol dependence cases, and normal subjects: A comparative study.

Authors:  Vidhata Dixit; Santosh Kumar; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2020-11-07

2.  Grammatical processing in schizophrenia: evidence from morphology.

Authors:  Matthew Walenski; Thomas W Weickert; Christopher J Maloof; Michael T Ullman
Journal:  Neuropsychologia       Date:  2010-01       Impact factor: 3.139

3.  The language profile of formal thought disorder.

Authors:  Derya Çokal; Gabriel Sevilla; William Stephen Jones; Vitor Zimmerer; Felicity Deamer; Maggie Douglas; Helen Spencer; Douglas Turkington; Nicol Ferrier; Rosemary Varley; Stuart Watson; Wolfram Hinzen
Journal:  NPJ Schizophr       Date:  2018-09-19

4.  Deficits in nominal reference identify thought disordered speech in a narrative production task.

Authors:  Gabriel Sevilla; Joana Rosselló; Raymond Salvador; Salvador Sarró; Laura López-Araquistain; Edith Pomarol-Clotet; Wolfram Hinzen
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.